Junyan Li

1.6k total citations · 1 hit paper
81 papers, 1.2k citations indexed

About

Junyan Li is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Junyan Li has authored 81 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 14 papers in Genetics and 8 papers in Cancer Research. Recurrent topics in Junyan Li's work include Fibroblast Growth Factor Research (11 papers), Epigenetics and DNA Methylation (11 papers) and Kruppel-like factors research (6 papers). Junyan Li is often cited by papers focused on Fibroblast Growth Factor Research (11 papers), Epigenetics and DNA Methylation (11 papers) and Kruppel-like factors research (6 papers). Junyan Li collaborates with scholars based in China, United States and Macao. Junyan Li's co-authors include Deshan Li, Guiping Ren, Xiaochen Guo, Wenfei Wang, Ruibing Wang, Yue‐Ming Jiang, Shuai Li, Yongyong Shi, Guoyin Feng and Ti Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Junyan Li

76 papers receiving 1.2k citations

Hit Papers

Oncolytic mineralized bacteria as potent locally administ... 2024 2026 2025 2024 10 20 30 40 50

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junyan Li China 21 610 154 127 101 98 81 1.2k
Yuko Doi Japan 21 390 0.6× 92 0.6× 89 0.7× 118 1.2× 114 1.2× 76 1.6k
Yanling Lin China 18 415 0.7× 110 0.7× 98 0.8× 71 0.7× 70 0.7× 61 1.0k
Thiago Verano‐Braga Brazil 19 844 1.4× 142 0.9× 281 2.2× 88 0.9× 103 1.1× 60 2.0k
Jônatas Bussador do Amaral Brazil 17 578 0.9× 84 0.5× 107 0.8× 91 0.9× 157 1.6× 76 1.3k
Nicolò Musso Italy 24 543 0.9× 223 1.4× 76 0.6× 84 0.8× 70 0.7× 90 1.8k
Julia Li Zhong China 26 759 1.2× 109 0.7× 67 0.5× 122 1.2× 124 1.3× 54 1.5k
Ji-Su Kim South Korea 20 555 0.9× 112 0.7× 126 1.0× 93 0.9× 122 1.2× 78 1.3k
Leoncio Vergara United States 21 785 1.3× 202 1.3× 64 0.5× 128 1.3× 179 1.8× 39 1.8k
Marı́a José De Rosa Argentina 15 828 1.4× 91 0.6× 47 0.4× 97 1.0× 166 1.7× 25 1.5k
Stephen J. Assinder Australia 20 844 1.4× 84 0.5× 118 0.9× 73 0.7× 75 0.8× 45 1.6k

Countries citing papers authored by Junyan Li

Since Specialization
Citations

This map shows the geographic impact of Junyan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junyan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junyan Li more than expected).

Fields of papers citing papers by Junyan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junyan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junyan Li. The network helps show where Junyan Li may publish in the future.

Co-authorship network of co-authors of Junyan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Junyan Li. A scholar is included among the top collaborators of Junyan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junyan Li. Junyan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, J., Weizheng Zhang, Qingjie Li, et al.. (2025). USP18 promotes nasopharyngeal carcinoma radioresistance via TRIM29 oligomerization and ubiquitination. Cell Death and Differentiation.
2.
Li, Junyan, et al.. (2025). USP39: a key regulator in malignant tumor progression. Frontiers in Oncology. 15. 1556011–1556011. 1 indexed citations
3.
Li, Qingjie, Xueliang Fang, Yingqin Li, et al.. (2024). DCAF7 Acts as A Scaffold to Recruit USP10 for G3BP1 Deubiquitylation and Facilitates Chemoresistance and Metastasis in Nasopharyngeal Carcinoma. Advanced Science. 11(36). e2403262–e2403262. 10 indexed citations
4.
Li, Junyan, et al.. (2024). Galangin alleviated Doxorubicin-induced cardiotoxicity by inhibiting ferroptosis through GSTP1/JNK pathway. Phytomedicine. 134. 155989–155989. 16 indexed citations
5.
Wang, Chenya, Liping Zhong, Jiachen Xu, et al.. (2024). Oncolytic mineralized bacteria as potent locally administered immunotherapeutics. Nature Biomedical Engineering. 8(5). 561–578. 59 indexed citations breakdown →
6.
Cheng, Qian, Xingping Quan, Ruifeng Luo, et al.. (2024). In Situ Colonization of Trojan‐Yeast for Targeted Glucose Starvation and Reconstruction of Tumor Immune Environment. Advanced Functional Materials. 34(34). 7 indexed citations
7.
Huang, Yanmin, et al.. (2024). Synthesis, antitumor activity evaluation of 2-selenocyano-3-selenocyanoalkyloxyestradiols with a bisselenocyanate structure. Bioorganic Chemistry. 144. 107149–107149. 6 indexed citations
8.
Wang, Xiaomin, et al.. (2023). Transcriptomics and Proteomics of Haemonchus contortus in Response to Ivermectin Treatment. Animals. 13(5). 919–919. 12 indexed citations
9.
Quan, Xingping, Xiao Liang, Yuan‐Fu Ding, et al.. (2023). Cryo-Shocked Platelet Coupled with ROS-Responsive Nanomedicine for Targeted Treatment of Thromboembolic Disease. ACS Nano. 17(7). 6519–6533. 45 indexed citations
10.
Li, Junyan, Yue Deng, Dongjie Peng, et al.. (2021). Sodium P-aminosalicylic Acid Attenuates Manganese-Induced Neuroinflammation in BV2 Microglia by Modulating NF-κB Pathway. Biological Trace Element Research. 199(12). 4688–4699. 11 indexed citations
11.
Fang, Yuanyuan, Dongjie Peng, Yuan Liang, et al.. (2020). Sodium P-aminosalicylic Acid Inhibits Manganese-Induced Neuroinflammation in BV2 Microglial Cells via NLRP3-CASP1 Inflammasome Pathway. Biological Trace Element Research. 199(9). 3423–3432. 18 indexed citations
12.
Sheng, Qianying, Yang Zhou, Junyan Li, et al.. (2020). Synthesis of Al3+-doping-TiO2 monodisperse microspheres and their application for phosphopeptides and glycopeptides enrichment. Talanta. 223(Pt 2). 121715–121715. 11 indexed citations
13.
Li, Junyan, et al.. (2018). Association of PPARG Gene Polymorphisms Pro12Ala with Type 2 Diabetes Mellitus: A Meta-analysis. Current Diabetes Reviews. 15(4). 277–283. 11 indexed citations
14.
Wang, Nan, Shuai Li, Xiaochen Guo, et al.. (2018). Fibroblast growth factor 21 improves glucose homeostasis partially via down-regulation of Na+-d-glucose cotransporter SGLT1 in the small intestine. Biomedicine & Pharmacotherapy. 109. 1070–1077. 11 indexed citations
15.
Li, Shuai, Xiaochen Guo, Teng Zhang, et al.. (2017). Fibroblast growth factor 21 ameliorates high glucose-induced fibrogenesis in mesangial cells through inhibiting STAT5 signaling pathway. Biomedicine & Pharmacotherapy. 93. 695–704. 22 indexed citations
17.
Xu, Pengfei, Yingjie Zhang, Liying Song, et al.. (2016). Efficacy of a combination of high and low dosage of PEGylated FGF-21 in treatment of diabetes in db/db mice. Biomedicine & Pharmacotherapy. 84. 97–105. 10 indexed citations
18.
Li, Tao, Zhen Zeng, Qian Zhao, et al.. (2012). FoxP2is significantly associated with schizophrenia and major depression in the Chinese Han Population. The World Journal of Biological Psychiatry. 14(2). 146–150. 34 indexed citations
19.
Zheng, Zirui, Junyan Li, Jing Sun, et al.. (2010). Inhibition of HBV replication by theophylline. Antiviral Research. 89(2). 149–155. 18 indexed citations
20.
Li, Junyan, et al.. (2009). Utilizing RNA/DNA hybridization to directly quantify mRNA levels in microbial fermentation samples. Journal of Microbiological Methods. 79(2). 205–210. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026